• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of oral corticosteroid on long-term weight following initiation of anti-IL-5/5Ra biologics in severe asthma.

作者信息

Shen Hsiao-Chin, Yong Su-Boon

机构信息

Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan.

Department of Allergy and Immunology, China Medical University Children's Hospital, Taichung, Taiwan; Department of Medicine, College of Medicine, China Medical University Children's Hospital, Taichung, Taiwan.

出版信息

J Allergy Clin Immunol Pract. 2024 Feb;12(2):534. doi: 10.1016/j.jaip.2023.11.017.

DOI:10.1016/j.jaip.2023.11.017
PMID:38336401
Abstract
摘要

相似文献

1
Impact of oral corticosteroid on long-term weight following initiation of anti-IL-5/5Ra biologics in severe asthma.
J Allergy Clin Immunol Pract. 2024 Feb;12(2):534. doi: 10.1016/j.jaip.2023.11.017.
2
Reply to "Impact of oral corticosteroid on long-term weight following initiation of anti-IL-5/5Ra biologics in severe asthma".
J Allergy Clin Immunol Pract. 2024 Feb;12(2):534-535. doi: 10.1016/j.jaip.2023.11.016.
3
Long-Term Weight Changes After Starting Anti-IL-5/5Ra Biologics in Severe Asthma: The Role of Oral Corticosteroids.重度哮喘患者开始使用抗IL-5/5Ra生物制剂后的长期体重变化：口服糖皮质激素的作用
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2748-2756.e3. doi: 10.1016/j.jaip.2023.06.054. Epub 2023 Jul 1.
4
Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis.靶向白细胞介素-5/5 受体生物制剂治疗伴有支气管扩张症的严重嗜酸性粒细胞性哮喘的真实世界疗效。
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2724-2731.e2. doi: 10.1016/j.jaip.2023.05.041. Epub 2023 Jun 7.
5
Are We Poised to Change the Trajectory of Maintenance Oral Corticosteroid Use in Severe Asthma in the Age of Biologics?在生物制剂时代，我们是否准备好改变重度哮喘维持性口服皮质类固醇的使用轨迹？
Chest. 2022 Jul;162(1):4-5. doi: 10.1016/j.chest.2022.04.004.
6
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.COVID-19 风险和结局在接受生物制剂或全身皮质类固醇治疗的成年哮喘患者中的：全国真实世界证据。
J Allergy Clin Immunol. 2021 Aug;148(2):361-367.e13. doi: 10.1016/j.jaci.2021.06.006. Epub 2021 Jun 15.
7
Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.奥马珠单抗可作为严重哮喘中慢性口服皮质类固醇替代疗法。
Respir Med. 2019 Apr;150:51-62. doi: 10.1016/j.rmed.2019.02.003. Epub 2019 Feb 7.
8
What is the current role of biologics in the management of patients with severe refractory asthma?生物制剂在重度难治性哮喘患者管理中的当前作用是什么？
Ann Allergy Asthma Immunol. 2016 May;116(5):383-7. doi: 10.1016/j.anai.2016.03.021.
9
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry.严重哮喘患者起始使用生物制剂对长期口服皮质类固醇或频繁使用急救皮质类固醇的影响（GLITTER）：来自国际严重哮喘登记处的数据。
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2732-2747. doi: 10.1016/j.jaip.2023.05.044. Epub 2023 Jun 8.
10
Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma.抗白细胞介素 5/5Ra 在嗜酸性粒细胞性哮喘中的累积皮质类固醇节省效应。
Eur Respir J. 2022 Nov 3;60(5). doi: 10.1183/13993003.02983-2021. Print 2022 Nov.